Healthcare Adapts to New Normal with Ariba

Leading Companies to Discuss Use of Technology-Based Solutions and Processes to Control Costs, Minimize Risk and Improve Competitive Advantage at Ariba LIVE

SUNNYVALE, Calif.--(BUSINESS WIRE)-- Supply market volatility. Capacity constraints. Global uncertainty. They’re the reality of doing business in the New Normal that all companies must deal with. Add to this calls for reform, regulatory uncertainty, competition from generic drugs, shrinking R&D pipelines and declining demand for elective procedures, and the reality becomes even more complex for healthcare concerns. On May 25, executives from top providers, producers, payers, and distributors will discuss these challenges and ways in which they can collaborate to overcome them during a Townhall Meeting at Ariba LIVE (www.aribalive.com), the premier conference for anyone engaged in buying, selling or managing cash, hosted by Ariba, Inc. (Nasdaq: ARBA), the leading spend management solutions provider.

“The future of healthcare has never been more uncertain,” said Mike Dunn, Director, Healthcare Accounts, Ariba. “From reform proposals and expiring patents to tight budgets and fewer resources, healthcare organizations face an unprecedented set of challenges that will require them to think and operate in different ways to overcome.”

During the Townhall Meeting at Ariba LIVE, leading companies across the healthcare industry will outline their challenges and explore ways in which they can leverage new solutions and processes to optimize their performance and enhance the results that they deliver.

“Change is the only thing that is certain in the New Normal,” Dunn continued. “Business needs and customer demands can change on a dime, and companies must be able to quickly and easily dial up the resources they need to meet them. Ariba’s solutions are uniquely designed to provide organizations with the support they need as they need it to do this.”

Delivered on-demand, Ariba’s solutions give companies everything that’s needed for agile business commerce, including:

  • Market-leading SaaS technology to optimize the complete commerce lifecycle – from source-to-settle and market-to-receipt
  • A web-based community to efficiently discover, connect and collaborate with a global network of trading partners
  • Capabilities to augment internal resources and skills with always-on expertise and commerce services

Many healthcare companies are already leveraging Ariba’s solutions to adapt to the New Normal, including: AstraZeneca, Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Genzyme Corporation, GlaxoSmithKline, Health Care Service Corporation, Hoffmann-La Roche Inc., Janssen Pharmaceutica & Research Foundation, Medtronic, Inc., Merck & Co., Inc., MetLife, Inc., Novartis AG, Pfizer Inc., Ranbaxy Laboratories Limited, Roche Pharmaceuticals, Sanofi-Aventis, Schering-Plough Corporation and West Penn Allegheny Health System, among others. They join 94 of the Fortune 100 and more than 295,000 other companies who rely on Ariba to control costs, minimize risks, improve profits and optimize cash flow and operations.

To learn more about Ariba’s offerings and the value they can deliver for your organization, visit www.ariba.com. For additional details on the Ariba LIVE Healthcare Townhall, or to register for the event, visit www.aribalive.com.

About Ariba, Inc.
Ariba, Inc. is the leading provider of on-demand spend management solutions. Our mission is to transform the way companies of all sizes, across all industries, and geographies operate by delivering technology, service, and network solutions that enable them to holistically source, contract, procure, pay, manage, and analyze their spend and supplier relationships. Delivered on demand, our enterprise-class offerings empower companies to achieve greater control of their spend and drive continuous improvements in financial and supply chain performance. More than 1,000 companies, including more than half of the companies on the Fortune 100, use Ariba solutions to manage their spend from sourcing and orders through invoicing and payment. For more information, visit www.ariba.com.

Copyright © 1996 – 2010 Ariba, Inc.
Ariba, the Ariba logo, Ariba LIVE, SupplyWatch, Ariba.com, Ariba.com Network and Ariba Spend Management. Find it. Get it. Keep it. are registered trademarks of Ariba, Inc. Ariba Spend Management, Ariba. This is Spend Management, Ariba Solutions Delivery, Ariba Analysis, Ariba Buyer, Ariba Category Management, Ariba Category Procurement, Ariba Contract Compliance, Ariba Contracts, Ariba Contract Management, Ariba Contract Workbench, Ariba Data Enrichment, Ariba eForms, Ariba Invoice, Ariba Payment, Ariba Sourcing, Ariba Spend Visibility, Ariba Travel and Expense, Ariba Procure-to-Pay, Ariba Workforce, Ariba Supplier Network, Ariba Supplier Connectivity, Ariba Supplier Performance Management, Ariba Content Procurement, Ariba PunchOut, Ariba QuickSource, PO-Flip, Ariba Spend Management Knowledge Base, Ariba Ready, Ariba Supply Lines, Ariba Supply Manager, Ariba LIVE, It’s Time for Spend Management and Supplier Lifecycle Management are trademarks or service marks of Ariba, Inc. All other brand or product names may be trademarks or registered trademarks of their respective companies or organizations in the United States and/or other countries.

Ariba Safe Harbor
Safe Harbor Statement under the Private Securities Litigation Reform Act 1995: Information and announcements in this release involve Ariba's expectations, beliefs, hopes, plans, intentions or strategies regarding the future and are forward-looking statements that involve risks and uncertainties. All forward-looking statements included in this release are based upon information available to Ariba as of the date of the release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to Ariba's operating and financial results to differ materially from current expectations include, but are not limited to: the impact of the credit crises on Ariba’s results of operations and financial condition; delays in development or shipment of new versions of Ariba's products and services; lack of market acceptance of Ariba's existing or future products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; the ability to attract and retain qualified employees; difficulties in assimilating acquired companies, long and unpredictable sales cycles and the deferrals of anticipated orders; declining economic conditions, including the impact of a recession; inability to control costs; changes in the company's pricing or compensation policies; significant fluctuations in our stock price; the outcome of and costs associated with pending or potential future regulatory or legal proceedings; the impact of our acquisitions, including the disruption or loss of customer, business partner, supplier or employee relationships; and the level of costs and expenses incurred by Ariba as a result of such transactions. Factors and risks associated with its business, including a number of the factors and risks described above, are discussed in Ariba's Form 10-Q filed with the SEC on February 5, 2010.



CONTACT:

Ariba, Inc.
Karen Master, 412-297-8177
[email protected]

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:   Technology  Data Management  Supply Chain Management  Networks  Other Technology  Transport  Practice Management  Health  Hospitals  Other Health  Logistics/Supply Chain Management  Professional Services  Accounting  Other Professional Services  Retail  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.